Hotchkis & Wiley Capital Management
VIVO

Hotchkis & Wiley Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-162,873
Closed -$2.83M – 551
2018
Q4 		$2.83M Sell
162,873
-68,298
-30% -$1.16M 0.01% 277
2018
Q3 		$3.44M Buy
231,171
+61,099
+36% +$947K 0.01% 287
2018
Q2 		$2.7M Buy
170,072
+142,867
+525% +$2.13M 0.01% 251
2018
Q1 		$386K Hold
27,205
– – ﹤0.01% 443
2017
Q4 		$381K Buy
+27,205
New +$398K ﹤0.01% 460

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Hotchkis & Wiley Capital Management's VIVO Position: Q1 2019 in Review

Hotchkis & Wiley Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2019, closing a stake of 162,873 shares — an estimated $2.83M sold.

Hotchkis & Wiley Capital Management first reported a position in VIVO in Q4 2017 and held it in 5 quarters. The position peaked at $3.44M in Q3 2018. 183 funds tracked by Wall St. Rank hold VIVO as of Q1 2019.

  • Hotchkis & Wiley Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2019 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 162,873 Meridian Bioscience Inc shares in Q1 2019, an estimated $2.83M.
  • Hotchkis & Wiley Capital Management first reported a position in Meridian Bioscience Inc in Q4 2017 and held it in 5 quarters.
  • Hotchkis & Wiley Capital Management's Meridian Bioscience Inc position peaked at $3.44M in Q3 2018.
  • 183 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2019.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2019, filed 14 May 2019.